Log In
BCIQ
Print this Print this
 

DNA

  Manage Alerts
Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting DNA

BCIQ
Print ChartPrint this
Marketed, 1 Marketed, 1 Marketed, 1 Marketed, 1 Marketed, 4 Marketed, 14 Marketed, 1 Marketed, 17 Marketed, 1 Approved, 5 Registration, 1 Registration, 1 Registration, 2 Phase III, 1 Phase III, 1 Phase III, 1 Phase III, 7 Pivotal, 1 Phase II/III, 1 Phase II, 10 Phase I/II, 5 Phase I, 1 Phase I, 1 Phase I, 1 Phase I, 5 Pilot, 5 Preclinical, 1 Preclinical, 6 Preclinical, 1 Preclinical, 1 Preclinical, 2 Discovery, 1
Phase of DevelopmentDiscoveryPreclinicalPilotPhase IPhase I/IIPhase IIPhase II/IIIPivotalPhase IIIRegistrationApprovedMarketed
Autoimmune

-

-

-

-

-

-

-

-

-

-

-

1

Cancer

-

2

-

5

5

10

1

1

7

2

5

17

Dermatology

-

-

-

-

-

-

-

-

-

-

-

1

Diagnostic

1

1

5

-

-

-

-

-

-

-

-

14

Hematology

-

-

-

-

-

-

-

-

1

-

-

4

Infectious

-

1

-

1

-

-

-

-

1

-

-

-

Musculoskeletal

-

6

-

-

-

-

-

-

-

1

-

-

Neurology

-

-

-

-

-

-

-

-

-

-

-

1

Ophthalmic

-

1

-

-

-

-

-

-

-

-

-

-

Other

-

-

-

1

-

-

-

-

1

-

-

-

Pulmonary

-

-

-

1

-

-

-

-

-

-

-

1

Renal

-

-

-

-

-

-

-

-

-

-

-

1

Transplant

-

-

-

-

-

-

-

-

-

1

-

1




 Products Targeting DNA
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

32

$195,786.1M

$172,933.8M

$516.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury Trial today